Default company panoramic image

Cell Microsystems, Inc.

Accelerating medical discovery by developing novel research tools supporting the basic research behind scientific and medical innovation.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Chapel Hill, NC, USA
  • Currency USD
  • Founded May 2010
  • Website

Company Summary

Cell Microsystems develops proprietary research tools for use in basic biology research labs. The IsoRaft Systems is a novel cell separation technology allowing scientists to perform existing experiments with a precision and elegance currently not available and new experiments that up to now have been impossible. A $1B+ market opportunity.


  • Default avatar
    Chris Morrison

    Chris Morrison has over 25 years of sales and business development experience bringing products to market. His principal expertise is his ability to formulate and execute strategic marketing and sales plans for new technologies and/or new markets. His domains of experience include pharmaceutical services, medtech, healthcare IT and clinical diagnostics. Since 2003,
    Chris has run ViaVerus, a healthcare and life science consulting firm specializi

  • Default avatar
    Chris Sims, MD

    Dr. Sims, a Professor at UNC with joint appointments in the Departments of Chemistry and Medicine, founded Cell Biosciences (now Protein Simple) along his colleague Nancy Allbritton in 2002. Drs. Sims, Allbritton and Wang were also founders of Intellego, Inc. which became a subsidiary of Amkor, Inc. Dr. Sims will join the company full time if and when it is appropriate.

  • Default avatar
    Gary Pace, PhD, Esq.
    VP, Legal Affairs and Corporate Strategy

    Dr. Pace is a registered patent attorney who has held executive positions with Novartis, Gentris Quill Medical, Inc. and BASF Corporation.

  • Default avatar
    Matt Megaro
    Business Advisor

    Matt is an expert in development stage life science companies. Most recentlyMatt was CEO of Quill Medical, Inc. sold to Angiotech Pharmaceuticals in 2006. Previously, he was President of Trimeris (took public in 1999) and CFO of Athena Neurosciences. Currently he is a director of Humacyte and serves as Executive-in-Residence for the Fuqua School of Business.